CYTK:NASDAQ
Cytokinetics, Inc.
US$72,29
arrow_upward
+2,23%(+1,58) 1D
US$72,29
0,00% (0,00)
bedtimeAfter hours
Closed: 4 ມິ.ຖ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
US$71,07
High
US$72,76
Low
US$70,72
Mkt. cap
໙,໘໐ ຕື້
Avg. vol.
໓,໐໒ ລ້ານ
Volume
໑,໓໑ ລ້ານ
52-wk high
US$80,20
52-wk low
US$31,52
EPS
US$-6,84
Beta
໐,໔໒
Shares outstanding
໑໒໔,໔໓ ລ້ານ
No. of employees
໖໗໓
Open
US$71,07
High
US$72,76
Low
US$70,72
Mkt. cap
໙,໘໐ ຕື້
Avg. vol.
໓,໐໒ ລ້ານ
Volume
໑,໓໑ ລ້ານ
52-wk high
US$80,20
52-wk low
US$31,52
EPS
US$-6,84
Beta
໐,໔໒
Shares outstanding
໑໒໔,໔໓ ລ້ານ
No. of employees
໖໗໓
Analyst outlook
Analyst Ratings
Based on 18 analysts giving stock ratings to CYTK in the past 3 months
Strong Buy
Buy
15
Hold
3
Sell
0
12 month forecast
Based on 18 Wall Street analysts offering 12 month price targets for CYTK in the last 3 months.
Highest
Current US$72,29
US$140,00 (+93,66%)
Average
US$100,35 (+38,82%)
Lowest
US$67,00 (-7,32%)
News stories
From sources across the web
Yahoo Finance
·
8 ຊົ່ວໂມງກ່ອນ
Why Is Cytokinetics (CYTK) Down 5.5% Since Last Earnings Report?
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websitecytokinetics.com
AI content may include mistakes. Learn more